Targeted therapy for KIF3C: A study on the mechanism of combined therapy with KIF3C signaling pathway, afatinib, and MT-DC (ac)phosphoramide in regulating gastric cancer cell proliferation
Year: 2024
Type: article
Source: Cellular Signalling
Institutions: Northern Jiangsu People's Hospital, Yangzhou University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G1885865200
OpenAlex ID: W4404592592